The Procter & Gamble (PG) Earnings Analysis
The Procter & Gamble (PG) next reports earnings on 2026-07-29, consensus EPS 1.43 USD. Last quarter (2026-04-24) it beat with EPS 1.59 USD vs 1.56 USD est (+1.9%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 21.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PG next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 1.43 USD |
| Revenue estimate | 21.38B |
PG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-24 | 1.59 USD | 1.56 USD | +1.9% | Beat |
| 2026-01-22 | 1.88 USD | 1.86 USD | +1.1% | Beat |
| 2025-10-24 | 1.99 USD | 1.9 USD | +4.7% | Beat |
| 2025-04-24 | 1.54 USD | 1.52 USD | +1.3% | Beat |
| 2025-01-22 | 1.88 USD | 1.89 USD | -0.5% | Miss |
| 2024-10-18 | 1.93 USD | 1.9 USD | +1.6% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
PG valuation and analyst view
| Trailing P/E | 21.34 |
|---|---|
| Trailing EPS | 6.896 USD |
| Price / book | 6.61 |
| Dividend yield | 2.86% |
| Market cap | 349.56B |
| Analyst consensus | Buy (28 buy / 23 hold / 1 sell) |
| Avg price target | 161.5 USD |
Related research pages
Frequently asked questions
When is The Procter & Gamble (PG)'s next earnings date?
The Procter & Gamble is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.43 USD and revenue estimate of 21.38B.
Did PG beat earnings last quarter?
In its 2026-04-24 report, PG posted EPS of 1.59 USD versus a 1.56 USD estimate — a beat of 1.9%.
What is PG's earnings track record?
Over the last 6 reported quarters with consensus data, PG beat estimates 5 times (83%).
What is PG's current P/E ratio and EPS?
PG trades at a trailing P/E of 21.34 on trailing EPS of 6.896337678460584 USD.
What do analysts rate PG?
Analyst consensus is "Buy" across 52 ratings (0 strong buy, 28 buy, 23 hold, 1 sell, 0 strong sell). Average 12-month price target: 161.5 USD.